Number of Shares
5,765.00
Current Holdings Value*
$463,280.00
% of Portfolio
5.07%
Total Estimate Gain
$82,415.03
% of Total Estimate Gain
11.65%

Amplify Treatments, Testing and Advancements ETF's BioNTech SE Holding Summary

As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 5,765.00 shares of BioNTech SE(BNTX), totaling $463,280.00. This investment constitutes 5.07% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding BioNTech SE(BNTX) stock.

The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $91.41 for 1,614.00 shares. Based on historical transaction data and BNTX's current price of $111.44, Amplify Treatments, Testing and Advancements ETF's estimated gain on his BNTX holdings is $82,415.03, reflecting a 11.65% gain to date.

Amplify Treatments, Testing and Advancements ETF BNTX ($111.44) Holding Chart

Amplify Treatments, Testing and Advancements ETF BNTX ($111.44) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1